Clinical Management of Potential Toxicity of Abemaciclib and Approaches to Ensure Treatment Continuation.

Shinya Takada,Hideki Maeda, Kengo Umehara, Sayuri Kuwahara, Mitsugu Yamamoto, Nobumoto Tomioka,Masato Takahashi,Kenichi Watanabe, Hirokazu Hashishita

Asian Pacific journal of cancer prevention : APJCP（2023）

引用 0|浏览6

暂无评分

摘要

In this study, the 100 and 200 mg/day groups had a longer TTF than the 300 mg/day group, and dose reduction was identified as an important factor in achieving longer TTF.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要